Virginia Retirement Systems Et Al Corcept Therapeutics Inc Transaction History

Virginia Retirement Systems Et Al

$15 Billion
Q3 2025

A detailed history of Virginia Retirement Systems Et Al transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 16,174 shares of CORT stock, worth $1.22 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

16,174

Previous 16,574 2.41%

Holding current value

$1.22 Million

Previous $1.22 Million 10.53%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 20, 2025	SELL	$67.17 - $83.9 $26,868 - $33,560	-400 Reduced 2.41%	16,174 $1.34 Million
Q2 2025 Jul 29, 2025	SELL	$62.24 - $91.93 $6,224 - $9,193	-100 Reduced 0.6%	16,574 $1.22 Million
Q1 2025 Jul 16, 2025	SELL	$49.85 - $114.22 $2.11 Million - $4.83 Million	-42,326 Reduced 71.74%	16,674 $1.9 Million
Q3 2023 Jan 02, 2024	SELL	$21.97 - $33.8 $114,244 - $175,759	-5,200 Reduced 8.1%	59,000 $1.61 Million
Q2 2023 Aug 22, 2023	SELL	$21.44 - $25.15 $19,296 - $22,635	-900 Reduced 1.38%	64,200 $1.43 Million
Q1 2023 Jul 11, 2023	BUY	$19.2 - $24.47 $318,720 - $406,202	16,600 Added 34.23%	65,100 $1.41 Million
Q4 2022 May 17, 2023	BUY	$19.95 - $29.96 $81,795 - $122,836	4,100 Added 9.23%	48,500 $985 Million
Q3 2022 May 16, 2023	SELL	$24.7 - $29.12 $402,610 - $474,656	-16,300 Reduced 26.85%	44,400 $1.14 Billion
Q1 2022 Apr 21, 2022	SELL	$16.53 - $25.21 $123,975 - $189,075	-7,500 Reduced 11.0%	60,700 $1.37 Million
Q4 2021 Feb 03, 2022	SELL	$17.1 - $23.34 $18,810 - $25,674	-1,100 Reduced 1.59%	68,200 $1.35 Million
Q3 2021 Oct 21, 2021	BUY	$19.68 - $22.53 $369,984 - $423,564	18,800 Added 37.23%	69,300 $1.36 Million
Q2 2021 Aug 13, 2021	BUY	$19.97 - $24.43 $43,934 - $53,746	2,200 Added 4.55%	50,500 $1.11 Million
Q1 2021 Apr 30, 2021	BUY	$23.49 - $30.56 $145,638 - $189,472	6,200 Added 14.73%	48,300 $1.15 Million
Q4 2020 Feb 16, 2021	SELL	$16.78 - $27.3 $127,528 - $207,480	-7,600 Reduced 15.29%	42,100 $1.1 Million
Q3 2020 Nov 12, 2020	SELL	$12.46 - $19.98 $240,478 - $385,614	-19,300 Reduced 27.97%	49,700 $865,000
Q2 2020 Aug 12, 2020	SELL	$11.0 - $18.26 $126,500 - $209,990	-11,500 Reduced 14.29%	69,000 $1.16 Million
Q1 2020 May 12, 2020	BUY	$10.11 - $14.04 $80,880 - $112,320	8,000 Added 11.03%	80,500 $957,000
Q4 2019 Jan 27, 2020	SELL	$12.06 - $16.96 $241,200 - $339,200	-20,000 Reduced 21.62%	72,500 $877,000
Q3 2019 Oct 22, 2019	SELL	$10.41 - $14.66 $90,567 - $127,542	-8,700 Reduced 8.6%	92,500 $1.31 Million
Q2 2019 Jul 26, 2019	SELL	$9.78 - $12.76 $192,666 - $251,372	-19,700 Reduced 16.29%	101,200 $1.13 Million
Q1 2019 Apr 25, 2019	BUY	$10.03 - $15.71 $484,448 - $758,793	48,300 Added 66.53%	120,900 $1.42 Million
Q4 2018 Feb 07, 2019	BUY	$11.29 - $17.19 $663,852 - $1.01 Million	58,800 Added 426.09%	72,600 $970,000
Q3 2018 Nov 02, 2018	SELL	$12.27 - $15.65 $784,053 - $1 Million	-63,900 Reduced 82.24%	13,800 $193,000
Q2 2018 Aug 03, 2018	BUY	$15.3 - $19.69 $1.19 Million - $1.53 Million	77,700 New	77,700 $1.22 Million

Others Institutions Holding CORT

# of Institutions

475

Shares Held

81.2M

Call Options Held

611K

Put Options Held

722K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $8.09B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.

Account

Virginia Retirement Systems Et Al Corcept Therapeutics Inc Transaction History